Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Johnson and Johnson
AstraZeneca
Queensland Health
Medtronic
US Department of Justice
Covington
UBS
Cipla

Generated: June 23, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,431,615

« Back to Dashboard

Which drugs does patent 8,431,615 protect, and when does it expire?

Patent 8,431,615 protects INCIVEK and is included in one NDA.

This patent has twenty patent family members in thirteen countries.

This patent has expired prematurely due to non-payment of maintenance fees. See details below.
Summary for Patent: 8,431,615
Title:Dose forms
Abstract: The present invention relates to antiviral therapies and compositions for treating or preventing Hepatitis C infections in patients and relates to other methods disclosed herein. The invention also relates to kits and pharmaceutical packs comprising compositions and dosage forms. The invention also relates to processes for preparing these compositions, dosages, kits, and packs.
Inventor(s): Chu; Hui-May (Natick, MA), Ette; Ene (Framingham, MA), McNair; Lindsay (Allston, MA), Alam; John (Cambridge, MA)
Assignee: Vertex Pharmaceuticals Incorporated (Cambridge, MA)
Application Number:11/264,746
Patent Claim Types:
see list of patent claims
Compound;

Drugs Protected by US Patent 8,431,615

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Vertex Pharms INCIVEK telaprevir TABLET;ORAL 201917-001 May 23, 2011 DISCN No No ➤ Sign Up ➤ Sign Up METHOD OF TREATING CHRONIC HEPATITIS C ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Colorcon
Medtronic
Dow
Queensland Health
Johnson and Johnson
Daiichi Sankyo
Boehringer Ingelheim
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.